Biopharmaceutical CMO Market to Surge to USD 51.5 Billion by 2032 Amid Rising Biologics Demand
Market Overview The Global Biopharmaceutical CMO Market is poised for significant growth in the coming decade. In 2023, the market was valued at approximately USD 18.2 billion, and it is expected to reach around USD 51.5 billion by 2032. This impressive expansion reflects a Compound Annual Growth Rate (CAGR) of 12.6% during the forecast period from 2023 to 2032. The Biopharmaceutical CMO Market research report delivers essential data, offering clients the insights necessary for making critical decisions. The report encompasses a detailed overview of the market, defining its scope, applications, and the latest developments in manufacturing technology. It tracks recent…
- Date: May 30, 2024
- Author: Thomas Bretz
- Category: PharmiWeb